Literature DB >> 2040665

Culture perfusion schedules influence the metabolic activity and granulocyte-macrophage colony-stimulating factor production rates of human bone marrow stromal cells.

J Caldwell1, B O Palsson, B Locey, S G Emerson.   

Abstract

The metabolic function and GM-CSF production rates of adherent human bone marrow stromal cells were investigated as functions of medium and serum feeding rates. A range of medium exchange schedules was studied, ranging from a typical Dexter culture protocol of one weekly medium exchange to a full media exchange daily, which more closely approximates what bone marrow cells experience in situ. Glucose consumption was found to be significantly higher at full daily exchange rate than at any other exchange schedule examined. However, the lactate yield on glucose was a constant, at 1.8 mol/mol, under all conditions considered. Differential serum vs. medium exchange experiment showed that both serum supply and medium nutrients were responsible for the altered behavior at high exchange rates. Glutamine consumption was found to be insignificant under all culture conditions examined. A change in exchange schedule from 50% daily medium exchange to full daily medium exchange after 14 days of culture was found to result in a transient production of GM-CSF and a change in metabolic behavior to resemble that of cultures which had full daily exchange from day one. These results suggest that both stromal cell metabolism and GM-CSF production are sensitive to medium exchange schedules. Taken together, the data presented indicate that attempts to model the function of human bone marrow in vitro may be well served by beginning with medium exchange schedules that more closely mimic the in vivo physiologic state of bone marrow.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2040665     DOI: 10.1002/jcp.1041470221

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  7 in total

1.  The influence of extra-cellular matrix and stroma remodeling on the productivity of long-term human bone marrow cultures.

Authors:  R M Schwartz; J Caldwell; M F Clarke; S G Emerson; B O Palsson
Journal:  Cytotechnology       Date:  1992       Impact factor: 2.058

2.  Angiogenic and osteogenic potential of bone repair cells for craniofacial regeneration.

Authors:  Darnell Kaigler; Giorgio Pagni; Chan-Ho Park; Susan A Tarle; Ronnda L Bartel; William V Giannobile
Journal:  Tissue Eng Part A       Date:  2010-09       Impact factor: 3.845

3.  Stem cell therapy for craniofacial bone regeneration: a randomized, controlled feasibility trial.

Authors:  Darnell Kaigler; Giorgio Pagni; Chan Ho Park; Thomas M Braun; Lindsay A Holman; Erica Yi; Susan A Tarle; Ronnda L Bartel; William V Giannobile
Journal:  Cell Transplant       Date:  2013       Impact factor: 4.064

4.  Rapid medium perfusion rate significantly increases the productivity and longevity of human bone marrow cultures.

Authors:  R M Schwartz; B O Palsson; S G Emerson
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-01       Impact factor: 11.205

5.  Transportation conditions for prompt use of ex vivo expanded and freshly harvested clinical-grade bone marrow mesenchymal stromal/stem cells for bone regeneration.

Authors:  Elena Veronesi; Alba Murgia; Anna Caselli; Giulia Grisendi; Maria Serena Piccinno; Valeria Rasini; Rosaria Giordano; Tiziana Montemurro; Philippe Bourin; Luc Sensebé; Markus T Rojewski; Hubert Schrezenmeier; Pierre Layrolle; Maria Pau Ginebra; Carmen Bunu Panaitescu; Enrique Gómez-Barrena; Fabio Catani; Paolo Paolucci; Jorge S Burns; Massimo Dominici
Journal:  Tissue Eng Part C Methods       Date:  2013-08-20       Impact factor: 3.056

Review 6.  Ex vivo expansion of umbilical cord blood: where are we?

Authors:  Omar S Aljitawi
Journal:  Int J Hematol       Date:  2012-03-23       Impact factor: 2.490

7.  Optimized cell survival and seeding efficiency for craniofacial tissue engineering using clinical stem cell therapy.

Authors:  Archana Rajan; Emily Eubanks; Sean Edwards; Sharon Aronovich; Suncica Travan; Ivan Rudek; Feng Wang; Alejandro Lanis; Darnell Kaigler
Journal:  Stem Cells Transl Med       Date:  2014-11-05       Impact factor: 6.940

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.